High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This Phase II, parallel-group, masked, randomized clinical trial aims to evaluate whether a DHA/ARA-enriched, fortified human milk diet administered during the first 14 days of life reduces respiratory morbidity and improves lung function in extremely preterm (EPT) infants (born at ≤28 weeks gestation).
Epistemonikos ID: 8138b31273bfa7ff5cb507e9c94fac9eeb7464d6
First added on: Dec 30, 2025